Role of posaconazole in the treatment of oropharyngeal candidiasis
Voichita Ianas1, Kathryn R Matthias2, Stephen A Klotz11Section of Infectious Diseases and Department of Medicine, 2School of Pharmacy, University of Arizona, Tucson, Arizona, USAAbstract: Posaconazole is the newest azole antifungal approved by the US Food and Drug Administration, and possesses a bro...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-06-01
|
| Series: | Infection and Drug Resistance |
| Online Access: | http://www.dovepress.com/role-of-posaconazole-in-the-treatment-of-oropharyngeal-candidiasis-a4689 |